Presentation is loading. Please wait.

Presentation is loading. Please wait.

Miguel Montero-Baker, MD, Gregory J

Published byChristina Dale Modified over 5 years ago

Similar presentations

Presentation on theme: "Miguel Montero-Baker, MD, Gregory J"— Presentation transcript:

1 Analysis of endovascular therapy for femoropopliteal disease with the Supera stent 
Miguel Montero-Baker, MD, Gregory J. Ziomek, BS, Luis Leon, MD, Aaron Gonzales, BS, Robert S. Dieter, MD, Crystal L. Gadd, MD, John P. Pacanowski, MD  Journal of Vascular Surgery  Volume 64, Issue 4, Pages (October 2016) DOI: /j.jvs Copyright © Terms and Conditions

2 Fig 1 Primary patency of the superficial femoral artery (SFA). SE, Standard error. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

3 Fig 2 Primary assisted patency of the superficial femoral artery (SFA). SE, Standard error. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

4 Fig 3 Secondary patency. SE, Standard error.
Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

5 Fig 4 Cox hazard ratio analysis. As seen in this image, a history of coronary artery disease (CAD) was found to be a protective factor against loss of patency. The other variables were associated with an increased risk of loss of patency. L, Long; M, medium. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © Terms and Conditions

Download ppt "Miguel Montero-Baker, MD, Gregory J"

Similar presentations

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results  M. Ferreira, L. Lanziotti, M. Monteiro, G.

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results  M. Ferreira, L. Lanziotti, M. Monteiro, G.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.
Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions 

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions 
Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease  Andrew J. Meltzer, MD, Gautam.

Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease  Andrew J. Meltzer, MD, Gautam.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Endovascular therapy for acute limb ischemia

Endovascular therapy for acute limb ischemia
Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.
Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament  Keith D. Calligaro, MD, Praveen Balraj, MD, Neil Moudgill, MD,

Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament  Keith D. Calligaro, MD, Praveen Balraj, MD, Neil Moudgill, MD,
Stenting of femoropopliteal lesions using interwoven nitinol stents

Stenting of femoropopliteal lesions using interwoven nitinol stents
Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score  Daniel M. Ihnat,

Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score  Daniel M. Ihnat,
Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A

Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A
A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients  Philip P. Goodney,
Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,

Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,
Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.
Danielle B. Cameron, BA, James H. Black, MD, Elliot K

Danielle B. Cameron, BA, James H. Black, MD, Elliot K
Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,
Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K
Adjunctive use of the superficial femoral vein for vascular reconstructions  Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Adjunctive use of the superficial femoral vein for vascular reconstructions  Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Similar presentations

Ads by Google